Lasa Supergenerics Ltd (LASA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.00",
    "chg": -0.24,
    "chgp": "-2.6%",
    "dir": -1,
    "prev_price": "9.24",
    "mcapval": "45.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE670X01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.28 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-lower-circuit-amid-heavy-selling-pressure-3725750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_stocks_hitting_lower_circuit_3725750.png",
        "date": "2025-11-24 15:00:09",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 24 Nov 2025 as it hit its lower circuit limit, reflecting intense selling pressure and a significant daily loss that outpaced both its sector and the broader market indices."
      },
      {
        "title": "Lasa Supergenerics Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-plunges-to-lower-circuit-amid-intense-selling-pressure-3725699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_only_sellers_3725699.png",
        "date": "2025-11-24 14:21:03",
        "description": "Lasa Supergenerics Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.91% today and exhibiting a complete absence of buyers. This extreme selling activity reflects distress signals as the pharmaceutical company continues to underperform against broader market indices and its sector peers."
      },
      {
        "title": "Why is Lasa Supergeneri falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lasa-supergeneri-fallingrising-3716464",
        "imagepath": "",
        "date": "2025-11-19 23:35:31",
        "description": "As of 19-Nov, Lasa Supergenerics Ltd is currently priced at 10.27, reflecting a slight increase of 0.02 (0.2%). The stock has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 18 Nov falling by 91.48% compared to the 5-day average. The stock has underperformed in the longer term, with a year-to-date decline of 60.26% and a 5-year decline of 86.66%, which suggests ongoing challenges despite today's minor uptick.\n\nIn the broader market context, Lasa Supergenerics' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.85% over the past week while Lasa has declined by 6.47%. This stark contrast highlights the stoc..."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 10.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-1076-3707147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_stocks_hitting_upper_circuit_3707147.png",
        "date": "2025-11-17 11:00:18",
        "description": "Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, with a notable increase in investor participation. The stock's trading volume surged significantly, reflecting strong market activity despite being below its moving averages across various time frames."
      },
      {
        "title": "How has been the historical performance of Lasa Supergeneri?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lasa-supergeneri-3703767",
        "imagepath": "",
        "date": "2025-11-15 00:12:35",
        "description": "Answer:\nThe historical performance of Lasa Supergeneri shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nLasa Supergeneri's net sales have varied, peaking at 202.38 Cr in March 2021 but declining to 142.45 Cr by March 2025, with a notable drop from 137.13 Cr in March 2022. Total operating income followed a similar trend, reflecting the same values as net sales. Raw material costs increased to 108.10 Cr in March 2025 from 79.28 Cr in March 2024, while total expenditure rose to 136.18 Cr in March 2025, indicating rising operational costs. Operating profit, which was positive at 47.22 Cr in March 2021, turned negative in March 2023 at -6.59 Cr and improved to 6.27 Cr by March 2025. Profit before tax remained negative, reaching -19.38 Cr in March 2025, with profit after tax also negative at -14.76 Cr. The company's equity capital remained stable at 50.10 Cr from March 2023 to M..."
      },
      {
        "title": "Why is Lasa Supergeneri falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lasa-supergeneri-fallingrising-3691327",
        "imagepath": "",
        "date": "2025-11-11 23:23:57",
        "description": "As of 11-Nov, Lasa Supergenerics Ltd is experiencing a decline in its stock price, currently at 10.76, which reflects a decrease of 0.56 or 4.95%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in an overall drop of 8.03%. It is trading below all key moving averages, indicating a bearish trend. Additionally, investor participation has decreased sharply, with delivery volume falling by 80.49% compared to the five-day average. The stock has also shown poor performance over various periods, with year-to-date returns down by 58.36% and a staggering 86.07% decline over the past five years.\n\nIn the broader market context, Lasa Supergenerics Ltd's recent performance contrasts sharply with the Sensex, which has gained 7.34% year-to-date. Over the past week, while the Sensex has increased by 0.49%, Lasa Supergenerics has declined by 7.88%, highlighting its..."
      }
    ],
    "total": 201,
    "sid": "1002834",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "15-Jan-2026",
      "details": "Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. January 02 2026 1. Appointment Of Mr. Ganesh Suresh Potdar As An Additional Director In Capacity Of (Executive Director) And Occupier Of All Units Of The Company.",
      "datetime": "02-Jan-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . January 02 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Dec-2025",
      "details": "Closure of trading window for the quarter ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lasa Supergenerics Hits Lower Circuit Amid Heavy Selling Pressure

2025-11-24 15:00:09

Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 24 Nov 2025 as it hit its lower circuit limit, reflecting intense selling pressure and a significant daily loss that outpaced both its sector and the broader market indices.

Lasa Supergenerics Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-11-24 14:21:03

Lasa Supergenerics Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.91% today and exhibiting a complete absence of buyers. This extreme selling activity reflects distress signals as the pharmaceutical company continues to underperform against broader market indices and its sector peers.

Why is Lasa Supergeneri falling/rising?

2025-11-19 23:35:31

As of 19-Nov, Lasa Supergenerics Ltd is currently priced at 10.27, reflecting a slight increase of 0.02 (0.2%). The stock has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 18 Nov falling by 91.48% compared to the 5-day average. The stock has underperformed in the longer term, with a year-to-date decline of 60.26% and a 5-year decline of 86.66%, which suggests ongoing challenges despite today's minor uptick. In the broader market context, Lasa Supergenerics' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.85% over the past week while Lasa has declined by 6.47%. This stark contrast highlights the stoc...

Lasa Supergenerics Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 10.76

2025-11-17 11:00:18

Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, with a notable increase in investor participation. The stock's trading volume surged significantly, reflecting strong market activity despite being below its moving averages across various time frames.

How has been the historical performance of Lasa Supergeneri?

2025-11-15 00:12:35

Answer: The historical performance of Lasa Supergeneri shows significant fluctuations in key financial metrics over the years. Breakdown: Lasa Supergeneri's net sales have varied, peaking at 202.38 Cr in March 2021 but declining to 142.45 Cr by March 2025, with a notable drop from 137.13 Cr in March 2022. Total operating income followed a similar trend, reflecting the same values as net sales. Raw material costs increased to 108.10 Cr in March 2025 from 79.28 Cr in March 2024, while total expenditure rose to 136.18 Cr in March 2025, indicating rising operational costs. Operating profit, which was positive at 47.22 Cr in March 2021, turned negative in March 2023 at -6.59 Cr and improved to 6.27 Cr by March 2025. Profit before tax remained negative, reaching -19.38 Cr in March 2025, with profit after tax also negative at -14.76 Cr. The company's equity capital remained stable at 50.10 Cr from March 2023 to M...

Why is Lasa Supergeneri falling/rising?

2025-11-11 23:23:57

As of 11-Nov, Lasa Supergenerics Ltd is experiencing a decline in its stock price, currently at 10.76, which reflects a decrease of 0.56 or 4.95%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in an overall drop of 8.03%. It is trading below all key moving averages, indicating a bearish trend. Additionally, investor participation has decreased sharply, with delivery volume falling by 80.49% compared to the five-day average. The stock has also shown poor performance over various periods, with year-to-date returns down by 58.36% and a staggering 86.07% decline over the past five years. In the broader market context, Lasa Supergenerics Ltd's recent performance contrasts sharply with the Sensex, which has gained 7.34% year-to-date. Over the past week, while the Sensex has increased by 0.49%, Lasa Supergenerics has declined by 7.88%, highlighting its...

View All News